US Stock MarketDetailed Quotes
GLSI Greenwich LifeSciences
- 14.320
- -0.900-5.91%
Close Sep 26 16:00 ET
- 14.340
- +0.020+0.14%
Post 20:02 ET
188.23MMarket Cap-18126P/E (TTM)
15.340High14.210Low28.87KVolume15.000Open15.220Pre Close425.17KTurnover0.49%Turnover RatioLossP/E (Static)13.14MShares21.44052wk High32.04P/B84.86MFloat Cap7.58052wk Low--Dividend TTM5.93MShs Float158.070Historical High--Div YieldTTM7.42%Amplitude3.262Historical Low14.729Avg Price1Lot Size
Greenwich LifeSciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.36%-1.05M | -14.50%-1.78M | -4.49%-6.48M | 0.73%-2.15M | -16.18%-1.8M | -81.52%-966.98K | 20.06%-1.56M | -44.47%-6.2M | 4.16%-2.17M | -73.23%-1.55M |
| Net income from continuing operations | -60.08%-2.61M | -16.39%-2.47M | -13.63%-8.89M | 1.57%-2.75M | -3.14%-2.39M | -118.26%-1.63M | -7.88%-2.12M | -71.21%-7.83M | -18.21%-2.79M | -168.68%-2.32M |
| Depreciation and amortization | 0.00%903 | 0.00%903 | 0.00%3.61K | 0.00%903 | 0.00%903 | 0.00%903 | 0.00%903 | 0.00%3.61K | 0.00%903 | 0.00%903 |
| Change In working capital | 1,360.36%963.42K | 448.35%95.21K | 125.76%31.5K | -111.51%-2.88K | -148.70%-4.26K | 648.21%65.97K | 81.02%-27.33K | 68.26%-122.27K | 135.78%25.03K | 104.43%8.75K |
| -Change in payables and accrued expense | 1,360.36%963.42K | 448.35%95.21K | 125.76%31.5K | -111.51%-2.88K | -148.70%-4.26K | 648.21%65.97K | 81.02%-27.33K | 68.26%-122.27K | 135.78%25.03K | 104.43%8.75K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.36%-1.05M | -14.50%-1.78M | -4.49%-6.48M | 0.73%-2.15M | -16.18%-1.8M | -81.52%-966.98K | 20.06%-1.56M | -44.47%-6.2M | 4.16%-2.17M | -73.23%-1.55M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.77M | 299.12K | 0 | 0 | 0 | 0 | 0 | -365.79%-7.54M | 0 | 0 |
| Net common stock issuance | --2.77M | --299.12K | --0 | --0 | --0 | --0 | --0 | ---7.54M | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --2.77M | --299.12K | --0 | --0 | --0 | --0 | --0 | -365.79%-7.54M | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -53.77%5.51M | -48.10%6.99M | -50.49%13.47M | -41.53%9.14M | -36.33%10.94M | -39.67%11.91M | -50.49%13.47M | -5.08%27.2M | -45.90%15.64M | -42.32%17.19M |
| Current changes in cash | 277.76%1.72M | 4.71%-1.48M | 52.84%-6.48M | 0.73%-2.15M | -16.18%-1.8M | 62.16%-966.98K | 79.13%-1.56M | -843.35%-13.74M | -27.52%-2.17M | -73.23%-1.55M |
| End cash Position | -33.98%7.22M | -53.77%5.51M | -48.10%6.99M | -48.10%6.99M | -41.53%9.14M | -36.33%10.94M | -39.67%11.91M | -50.49%13.47M | -50.49%13.47M | -45.90%15.64M |
| Free cash flow | -8.36%-1.05M | -14.50%-1.78M | -4.49%-6.48M | 0.73%-2.15M | -16.18%-1.8M | -81.52%-966.98K | 20.06%-1.56M | -44.47%-6.2M | 4.16%-2.17M | -73.23%-1.55M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data